CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s DiseaseBence György, Martin Ingelsson, Lars Lannfelt et al.|Molecular Therapy — Nucleic Acids|2018Cited by 189